Literature DB >> 8220418

Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected].

B T Lamb1, S S Sisodia, A M Lawler, H H Slunt, C A Kitt, W G Kearns, P L Pearson, D L Price, J D Gearhart.   

Abstract

Overexpression of the gene encoding the beta-amyloid precursor protein (APP) may have a key role in the pathogenesis of both Alzheimer's disease (AD) and Down Syndrome (DS). We have therefore introduced a 650 kilobase (kb) yeast artificial chromosome (YAC) that contains the entire, unrearranged 400 kb human APP gene into mouse embryonic stem (ES) cells by lipid-mediated transfection. ES lines were generated that contain a stably integrated, unrearranged human APP gene. Moreover, we demonstrate germ line transmission of the APP YAC in transgenic mice and expression of human APP mRNA and protein at levels comparable to endogenous APP. This transgenic strategy may prove invaluable for the development of mouse models for AD and DS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8220418     DOI: 10.1038/ng0993-22

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  61 in total

1.  Xist yeast artificial chromosome transgenes function as X-inactivation centers only in multicopy arrays and not as single copies.

Authors:  E Heard; F Mongelard; D Arnaud; P Avner
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 2.  Modeling human neurodegenerative diseases in transgenic systems.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Gregory A Elder
Journal:  Hum Genet       Date:  2011-12-14       Impact factor: 4.132

3.  Lens defects and age-related fiber cell degeneration in a mouse model of increased AbetaPP gene dosage in Down syndrome.

Authors:  Peter H Frederikse; Xiao-Ou Ren
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

4.  CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.

Authors:  Sungho Lee; Nicholas H Varvel; Megan E Konerth; Guixiang Xu; Astrid E Cardona; Richard M Ransohoff; Bruce T Lamb
Journal:  Am J Pathol       Date:  2010-09-23       Impact factor: 4.307

Review 5.  Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.

Authors:  Masashi Kitazawa; Rodrigo Medeiros; Frank M Laferla
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 6.  Alzheimer's disease: fundamental and therapeutic aspects.

Authors:  M Schorderet
Journal:  Experientia       Date:  1995-02-15

7.  Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease.

Authors:  Muthuswamy Anantharaman; Jitbanjong Tangpong; Jeffery N Keller; Michael P Murphy; William R Markesbery; Kelley K Kiningham; Daret K St Clair
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

8.  Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1).

Authors:  Luzhou Xing; Martha Salas; Hong Zhang; Julia Gittler; Thomas Ludwig; Chyuan-Sheng Lin; Vundavalli V Murty; Wayne Silverman; Ottavio Arancio; Benjamin Tycko
Journal:  Mamm Genome       Date:  2012-10-25       Impact factor: 2.957

9.  Down-regulation of the Notch pathway mediated by a gamma-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemia.

Authors:  J Tammam; C Ware; C Efferson; J O'Neil; S Rao; X Qu; J Gorenstein; M Angagaw; H Kim; C Kenific; K Kunii; K J Leach; G Nikov; J Zhao; X Dai; J Hardwick; M Scott; C Winter; L Bristow; C Elbi; J F Reilly; T Look; G Draetta; Lht Van der Ploeg; N E Kohl; P R Strack; P K Majumder
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

10.  NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease.

Authors:  Nicholas H Varvel; Kiran Bhaskar; Maria Z Kounnas; Steven L Wagner; Yan Yang; Bruce T Lamb; Karl Herrup
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.